Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The approach to the diagnosis of severe combined immunodeficiency disease (SCID) and related disorders varies among institutions and countries.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Allergy Clin. Immunol.

Title: The Journal of allergy and clinical immunology

Publisher: Elsevier BV

ISSN (Electronic): 1097-6825

ISSN (Print): 0091-6749

Publication date (Electronic): Apr 2014

Volume: 133

Issue: 4

Affiliations

[1 ] Department of Pediatrics, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex. Electronic address: wtshearer@texaschildrens.org.

[2 ] Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.

[3 ] Division of Biostatistics, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wis.

[4 ] Division of Immunology and the Manton Center for Orphan Disease Research, Children's Hospital Boston, and Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass.

[5 ] Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

[6 ] Departments of Microbiology, Immunology & Molecular Genetics and Pediatrics, University of California, Los Angeles, Calif.

[7 ] Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

[8 ] Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.

[9 ] Division of Hematology and Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass.

[10 ] Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, Tex.

[11 ] Department of Pediatrics and Immunology, Duke University Medical Center, Durham, NC.

Article

Publisher Item ID: S0091-6749(13)01495-4 Mid ID: NIHMS547071

DOI: 10.1016/j.jaci.2013.09.044

PMC ID: 3972266

PubMed ID: 24290292

SO-VID: 06e22509-1302-405b-bff2-5c5c89860aae

History

Keywords: Allogeneic hematopoietic cell transplantation,clinical trial,gene therapy,primary immunodeficiency

Data availability:

Keywords: Allogeneic hematopoietic cell transplantation, clinical trial, gene therapy, primary immunodeficiency

Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

Read this article at

Abstract

Related collections

Drug Repurposing

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 91